Morgan Stanley Milestone Pharmaceuticals Inc. Put Options Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MIST
# of Institutions
54Shares Held
18.6MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$9.89 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$5.64 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.99 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.57 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.78 Million1.22% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $59.7M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...